Multiple Sclerosis International Federation

 
 
News
Donate advanced search
print version print this page
 

inside
News:

 

  MS News

Summaries of news from MS websites around the world. Links will take you to the source articles.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate

DKNY and UK MS Society join forces for book launch

On 29 October 2009, 140 people attended the launch of Marlo Parmelee's book ‘Awkward Bitch – My Life with MS,’ at the Donna Karan New York (DKNY) clothes store in London.

New data support early interferon treatment for multiple sclerosis

In a study of 2,570 people with MS, early treatment with interferon therapy was associated with a significant reduction in the risk of MS progression.

Teenage obesity linked to MS

New research has investigated the possibility that teenage obesity may be linked with an increased risk of MS in women.

New York Marathon 2009: raising MS awareness and more than US$210k

On 1 November 2009 more than 50 people raised awareness and funds for MS by taking part in the New York Marathon. These included Indian actor and model Milind Soman, representatives from the Southern New York Chapter of the National MS Society and Zoe Koplowitz, who has MS and completed her 21st New York Marathon in 28 hours and 45 minutes.

Update on Tysabri and PML: Company Releases Details of Cases and Risks

According to information released by Biogen Idec, there have been 24 confirmed cases of progressive multifocal leukoencephalopathy (PML, a viral infection of the brain that usually leads to death or severe disability) among people who have used Tysabri® (natalizumab, Biogen Idec and Elan Pharmaceuticals) after it became available for prescription in July 2006.

Results published from rituximab study in primary progressive MS

A study of intravenous rituximab (Rituxan®, Genentech and Biogen Idec) in 439 people with primary progressive MS has shown that the drug did not slow disease progression when compared with inactive placebo, the primary endpoint of the study.

"Una Mela per la Vita" (an apple for life) campaign raises funds and awareness in Italy

The Italian MS Society, Associazione Italiana Sclerosi Multipla (AISM), held their "Una Mela per la Vita" fundraising and awareness campaign on 10-11 October 2009. The campaign saw events in 3,000 places across Italy and raised €2,205,000.

Researchers show how immune attack may directly damage nerve fibres in MS

Researchers report on a protein that may engage the immune attack to target nerve fibres in MS; studies suggest that damage to nerve fibres may be the root cause of long-term disability in MS.

26 new research projects launched totalling US$9.2 Million to propel MS research

The US National MS Society has just committed US$9.2 million to launch 26 new MS research projects as part of its comprehensive research programme and commitment to move research forward.

European drug agency to weigh risks/benefits of Tysabri - cites 23 cases of PML

The European Medicines Agency has released a statement indicating that one of its advisory committees will launch a review of the risks and benefits of Tysabri in light of 23 confirmed cases of progressive multifocal leukoencephalopathy (PML) that it says have occurred since the drug has been on the market.
Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top